Barclays PLC Buys 53,991 Shares of Xometry, Inc. (NASDAQ:XMTR)

Barclays PLC boosted its position in shares of Xometry, Inc. (NASDAQ:XMTR) by 360.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 68,951 shares of the company’s stock after purchasing an additional 53,991 shares during the period. Barclays PLC owned about 0.14% of Xometry worth $1,266,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Bank of New York Mellon Corp boosted its holdings in shares of Xometry by 21.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 140,522 shares of the company’s stock valued at $1,624,000 after buying an additional 25,247 shares during the last quarter. Commonwealth Equity Services LLC increased its stake in shares of Xometry by 66.0% during the 2nd quarter. Commonwealth Equity Services LLC now owns 25,403 shares of the company’s stock worth $294,000 after purchasing an additional 10,103 shares during the last quarter. Rhumbline Advisers raised its holdings in shares of Xometry by 6.8% in the 2nd quarter. Rhumbline Advisers now owns 58,002 shares of the company’s stock valued at $670,000 after purchasing an additional 3,690 shares during the period. Dimensional Fund Advisors LP lifted its stake in Xometry by 44.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 493,847 shares of the company’s stock valued at $5,712,000 after purchasing an additional 153,107 shares during the last quarter. Finally, Primecap Management Co. CA grew its holdings in Xometry by 1.4% during the second quarter. Primecap Management Co. CA now owns 6,804,988 shares of the company’s stock worth $78,666,000 after purchasing an additional 93,350 shares during the period. Institutional investors and hedge funds own 97.31% of the company’s stock.

Xometry Stock Down 1.8 %

Shares of NASDAQ:XMTR opened at $32.92 on Tuesday. The firm has a fifty day moving average of $35.01 and a 200 day moving average of $23.42. Xometry, Inc. has a 52-week low of $11.08 and a 52-week high of $45.33. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.55 and a current ratio of 4.59. The firm has a market capitalization of $1.63 billion, a PE ratio of -31.35 and a beta of 0.70.

Insider Transactions at Xometry

In other Xometry news, Director Emily Rollins sold 3,729 shares of the business’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $29.49, for a total value of $109,968.21. Following the completion of the sale, the director now directly owns 12,457 shares of the company’s stock, valued at $367,356.93. The trade was a 23.04 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Peter Goguen sold 5,000 shares of the firm’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $32.00, for a total value of $160,000.00. Following the transaction, the chief operating officer now directly owns 175,419 shares in the company, valued at $5,613,408. This trade represents a 2.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 44,605 shares of company stock worth $1,430,140. 16.79% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Wedbush reaffirmed an “outperform” rating and set a $48.00 target price on shares of Xometry in a report on Friday, December 20th. Royal Bank of Canada upped their target price on Xometry from $27.00 to $40.00 and gave the company a “sector perform” rating in a research report on Friday, January 3rd. Cantor Fitzgerald reissued an “underweight” rating and set a $12.00 price target on shares of Xometry in a report on Wednesday, November 6th. JPMorgan Chase & Co. raised Xometry from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $25.00 to $45.00 in a report on Wednesday, December 18th. Finally, UBS Group increased their price objective on Xometry from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $33.33.

About Xometry

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.